Nasdaq - Delayed Quote USD

Fidelity Disruptive Medicine Fund (FRXNX)

11.71
+0.11
+(0.95%)
As of January 23 at 8:01:17 PM EST. Market Open.
Loading Chart for FRXNX
  • Previous Close 11.60
  • YTD Return 6.65%
  • Expense Ratio 0.00%
  • Category Health
  • Last Cap Gain -22.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 45.02M
  • Beta (5Y Monthly) 0.79
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 47.00%
  • Last Dividend --
  • Inception Date Apr 16, 2020

Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.

Fidelity Investments

Fund Family

Health

Fund Category

45.02M

Net Assets

2020-04-16

Inception Date

Performance Overview: FRXNX

View More

Trailing returns as of 5/1/2023. Category is Health.

YTD Return

FRXNX
6.65%
Category
7.95%
 

1-Year Return

FRXNX
11.10%
Category
30.16%
 

3-Year Return

FRXNX
5.92%
Category
16.10%
 

5-Year Return

FRXNX
0.00%
Category
15.71%
 

Holdings: FRXNX

View More

Sector Weightings

SectorFRXNX
Healthcare   99.46%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: FRXNX

View More

Research Reports: FRXNX

View More

Top Mutual Funds